SCHEMBL5613148

SCHEMBL5613148

C[C@H]1O[C@@H](n2cnc(C(N)=O)n2)[C@H](O)[C@@H]1O

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PNP P00491 4/20 0.75
▸ LMNA P02545 3/20 0.67
▸ SMN1; SMN2 Q16637 2/20 0.67
▸ ADORA1 P30542 2/20 0.67
▸ ALDH1A1 P00352 1/20 0.67
▸ GLA P06280 1/20 0.67
▸ EIF4E P06730 1/20 0.67
▸ CYP3A4 P08684 1/20 0.67
▸ TOP1 P11387 1/20 0.67
▸ TSHR P16473 1/20 0.67
▸ THPO P40225 1/20 0.67
▸ PMP22 Q01453 1/20 0.67
▸ ADK P55263 8/20 0.45
▸ HTR2C P28335 1/20 0.45
▸ HTR2B P41595 1/20 0.45
▸ SLC6A3 Q01959 1/20 0.45
▸ TMEM97 Q5BJF2 1/20 0.45
▸ ADORA3 P0DMS8 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7754419 1.00 PNP (0.75) PNPLMNASMN1; SMN2ADORA1ALDH1A1
SCHEMBL15019632 1.00 PNP (0.75) PNPLMNASMN1; SMN2ADORA1ALDH1A1
SCHEMBL12149488 0.85 LMNA (0.75) PNPLMNASMN1; SMN2ADORA1ALDH1A1
SCHEMBL12149489 0.85 LMNA (0.75) PNPLMNASMN1; SMN2ADORA1ALDH1A1
SCHEMBL15253047 0.83 LMNA (0.67) PNPLMNASMN1; SMN2ADORA1ALDH1A1
SCHEMBL14108533 0.82 LMNA (0.79) PNPLMNASMN1; SMN2ADORA1ALDH1A1
SCHEMBL15019611 0.82 LMNA (0.79) PNPLMNASMN1; SMN2ADORA1ALDH1A1
SCHEMBL12150452 0.82 LMNA (0.79) PNPLMNASMN1; SMN2ADORA1ALDH1A1
SCHEMBL12149570 0.82 LMNA (0.63) PNPLMNASMN1; SMN2ADORA1ALDH1A1
Ribavirin SCHEMBL4064991 0.81 LMNA (1.00) PNPLMNASMN1; SMN2ADORA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070134255-A1 Hmpv treatment with ribavirin and anti-hmpv antibody VIRONOVATIVE B.V. (NL) 2007-06-14 — — US disclosed
WO-2004096241-A1 HMPV TREATMENT WITH RIBAVIRIN AND ANTI-HMPV ANTIBODY VIRONOVATIVE B.V. (NL) 2004-11-11 — — WO disclosed
EP-1244356-A4 COMPOSITIONS AND METHODS FOR L-NUCLEOSIDES, L-NUCLEOTIDES, AND THEIR ANALOGS ICN PHARMACEUTICALS (US) 2003-03-19 — — EP disclosed
EP-1244356-A1 COMPOSITIONS AND METHODS FOR L-NUCLEOSIDES, L-NUCLEOTIDES, AND THEIR ANALOGS ICN Pharmaceuticals, Inc. (US) 2002-10-02 — — EP disclosed
WO-2001045642-A2 PULMONARY DELIVERY OF RIBAVIRIN OR LEVOVIRIN™ FOR SYSTEMIC AND QUASI-SYSTEMIC TREATMENT OF DISEASE ICN PHARMACEUTICALS, INC. (US) 2001-06-28 — — WO disclosed
WO-2001045509-A1 COMPOSITIONS AND METHODS FOR L-NUCLEOSIDES, L-NUCLEOTIDES, AND THEIR ANALOGS ICN PHARMACEUTICALS, INC. (US) 2001-06-28 — — WO disclosed
Send feedback